The MS-HRM results showed that the NID2 promoter is methylated in HONE1, HK1, and C666 (NPC cell lines), when compared to the unmethylated immortalized nasopharyngeal cell lines (NP69 and NP460). The gene discussed is NID2; the disease is nasopharyngeal carcinoma.